Clinical Trial Results:
A Safety and Efficacy Trial Evaluating the Use of Apixaban in the
Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary
Embolism.
Revised Protocol Number 02 incorporating Amendment(s) 04 and
Administrative Letters 02, 03 and 04
+ Protocol Amendment 01 (version 1.0 dated 21-Apr-08) Site-specific -
Molecular Profiling Supplement Samples For Pfizer's Exploratory
Research Biobank
Summary
|
|
EudraCT number |
2007-007867-25 |
Trial protocol |
DE FR AT HU ES PT DK CZ IT |
Global completion date |
12 Mar 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Dec 2016
|
First version publication date |
08 Dec 2016
|
Other versions |
|
Summary report(s) |
CV185-056_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.